Yuping Wei

Yuping Wei

Auto-generated profile, based on publicly available information

Yuping Wei

Department of Gastroenterology, The Third People’s Hospital of Chengdu, Chengdu, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YWYuping Wei
Yuping Wei
JLJinting Li
Jinting Li
JLJiao Li
Jiao Li
CLChuan Liu
Chuan Liu
XGXingzhou Guo
Xingzhou Guo
WDWeiguo Dong
Weiguo Dong
The Western diet, characterized by its high content of long-chain fatty acids (LCFAs), is widely recognized as a significant triggering factor for inflammatory bowel disease (IBD). While the link between a high-fat diet and colitis has been observed, the specific effects and mechanisms remain incompletely understood. Our study provides evidence that the diet rich in LCFAs can disrupt the integrity of the intestinal barrier and exacerbate experimental colitis in mice. Mechanistically, LCFAs upregulate the signal transducer and activator of transcription-3 (STAT3) pathway in the inflammatory model, and STAT3 knockout effectively counters the pro-inflammatory effects of LCFAs on colitis. Specifically, palmitic acid (PA), a representative LCFA, enters intestinal epithelial cells via the cluster of differentiation 36 (CD36) pathway and participates in the palmitoylation cycle of STAT3. Inhibiting this cycle using pharmacological inhibitors like 2-Bromopalmitate (2-BP) and ML349, as well as DHHC7 knockdown, has the ability to alleviate inflammation induced by PA. These findings highlight the significant role of dietary LCFAs, especially PA, in the development and progression of IBD. Diet adjustments and targeted modulation offer potential therapeutic strategies for managing this condition.

7 January 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
ZLZhengru Liu
Zhengru Liu
JLJian Liu
Jian Liu
YWYuping Wei
Yuping Wei
JLJinting Li
Jinting Li
WDWeiguo Dong
Weiguo Dong
WDWeiguo Dong
Weiguo Dong
Ubiquitin-specific protease 25 (USP25), a member of the deubiquitination family, plays an important role in protein ubiquitination, degradation, inflammation, and immune regulation. However, the role and mechanism of USP25 in ulcerative colitis (UC) remain unclear. To study the role and mechanism of USP25 in UC, bioinformatics analysis and research are conducted on clinical patients with UC, Usp25 knockout (Usp25 −/− ) mice, intestinal epithelial cell-specific knockout signal transducer and activator of transcription 3 (Stat3) (Villin-Cre Stat3fl/fl) mice, and human colonic epithelial cells. Results show that the expression of USP25 is decreased in patients with UC and mice with dextran sulfate sodium salt (DSS)-induced colitis and that USP25 deficiency exacerbates UC by destroying the intestinal mucosal barrier, however, overexpression of USP25 can alleviate colitis. Mechanistically, USP25 reduces the degradation of phosphor-STAT3Y705 at lysine 409 by catalyzing K48-linked deubiquitination. Further, this study demonstrates the aggravation of DSS-induced colitis by intestinal epithelial cell-specific knockout Stat3 in mice, while Stat3 overexpression by adeno-associated virus attenuates colitis in DSS-induced Usp25 −/− mice. Together, these results showed that USP25 ameliorates UC by regulating the degradation of phosphor-STAT3. Collectively, USP25 is a specific STAT3 regulator that can be targeted in UC.

26 March 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
ZLZhengru Liu
Zhengru Liu
JLJian Liu
Jian Liu
YWYuping Wei
Yuping Wei
JLJinting Li
Jinting Li
WDWeiguo Dong
Weiguo Dong
WDWeiguo Dong
Weiguo Dong